Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To determine whether simvastatin at a dose of 80mg can reduce the rate of whole brain
atrophy, as measured by MRI, over a 2-year time-period when compared to placebo.